title: Imaging of brain hypoxia in permanent and temporary middle cerebral artery occlusion in the rat using 18F-fluoromisonidazole and positron emission tomography: a pilot study.
abstract: In acute stroke, the target of therapy is the severely hypoxic but salvageable tissue. Previous human studies using 18F-fluoromisonidazole and positron emission tomography (18F-FMISO PET) have shown high tracer retention indicative of tissue hypoxia, which had normalized at repeat scan >48 h later. In the only validation study of 18F-FMISO, using ex vivo autoradiography in thread middle cerebral artery occluded (MCAo) rats, there was unexpected high uptake as late as 22 h after reperfusion, raising questions about the use of 18F-FMISO as a hypoxia tracer. Here we report a pilot study of 18F-FMISO PET in experimental stroke. Spontaneous hypertensive rats were subjected to distal clip MCAo. Three-hour dynamic PET was performed in 7 rats: 3 normals, 1 with permanent MCAo (two sessions: 30 mins and 48 h after clip), and 3 with temporary MCAo (45 mins, n=1; 120 mins, n=2; scanning started 30 mins after clip removal). Experiments were terminated by perfusion-fixation for standard histopathology. Late tracer retention was assessed by both compartmental modelling and simple side-to-side ratios. In the initial PET session of the permanent MCAo rat, striking trapping of 18F-FMISO was observed in the affected cortex, which had normalized 48 h later; histopathology revealed pannecrosis. In contrast, there was no demonstrable tracer retention in either temporary MCAo models, and histopathology showed ischemic changes only. These results document elevated 18F-FMISO uptake in the stroke area only in the early phase of MCAo, but not after early reperfusion nor when tissue necrosis has developed. These findings strongly support the validity of 18F-FMISO as a marker of viable hypoxic tissue/penumbra after stroke.
authors.affiliation: Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
authors.forename: Masashi
authors.initials: M
authors.lastname: Takasawa
authors.forename: John S
authors.initials: JS
authors.lastname: Beech
authors.forename: Tim D
authors.initials: TD
authors.lastname: Fryer
authors.forename: Young T
authors.initials: YT
authors.lastname: Hong
authors.forename: Jessica L
authors.initials: JL
authors.lastname: Hughes
authors.forename: Keiji
authors.initials: K
authors.lastname: Igase
authors.forename: P Simon
authors.initials: PS
authors.lastname: Jones
authors.forename: Rob
authors.initials: R
authors.lastname: Smith
authors.forename: Franklin I
authors.initials: FI
authors.lastname: Aigbirhio
authors.forename: David K
authors.initials: DK
authors.lastname: Menon
authors.forename: John C
authors.initials: JC
authors.lastname: Clark
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Baron
mesh_terms: D000758:Anesthesia; D000818:Animals; D002534:Hypoxia, Brain / Q000000981:diagnostic imaging* / Q000473:pathology; D007090:Image Interpretation, Computer-Assisted; D020244:Infarction, Middle Cerebral Artery / Q000000981:diagnostic imaging / Q000473:pathology; D007700:Kinetics; D008026:Ligation; D008297:Male; D020768:Middle Cerebral Artery / Q000502:physiology*; D008920:Misonidazole / Q000031:analogs & derivatives; D008954:Models, Biological; D009336:Necrosis; D010865:Pilot Projects; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D051381:Rats; D011918:Rats, Inbred SHR; D020521:Stroke / Q000000981:diagnostic imaging / Q000473:pathology
chemical_list: D019275:Radiopharmaceuticals; C031843:fluoromisonidazole; D008920:Misonidazole